256 related articles for article (PubMed ID: 26137861)
1. Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.
Du Bois P; Pablo Tortola C; Lodka D; Kny M; Schmidt F; Song K; Schmidt S; Bassel-Duby R; Olson EN; Fielitz J
Circ Res; 2015 Aug; 117(5):424-36. PubMed ID: 26137861
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
3. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.
Bowen TS; Adams V; Werner S; Fischer T; Vinke P; Brogger MN; Mangner N; Linke A; Sehr P; Lewis J; Labeit D; Gasch A; Labeit S
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):939-953. PubMed ID: 28887874
[TBL] [Abstract][Full Text] [Related]
5. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.
Rezk BM; Yoshida T; Semprun-Prieto L; Higashi Y; Sukhanov S; Delafontaine P
PLoS One; 2012; 7(1):e30276. PubMed ID: 22276172
[TBL] [Abstract][Full Text] [Related]
7. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
Eddins MJ; Marblestone JG; Suresh Kumar KG; Leach CA; Sterner DE; Mattern MR; Nicholson B
Cell Biochem Biophys; 2011 Jun; 60(1-2):113-8. PubMed ID: 21448668
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.
Shen C; Zhou J; Wang X; Yu XY; Liang C; Liu B; Pan X; Zhao Q; Song JL; Wang J; Bao M; Wu C; Li Y; Song YH
EBioMedicine; 2017 Feb; 16():238-250. PubMed ID: 28161398
[TBL] [Abstract][Full Text] [Related]
11. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model.
Nguyen T; Bowen TS; Augstein A; Schauer A; Gasch A; Linke A; Labeit S; Adams V
Skelet Muscle; 2020 Apr; 10(1):12. PubMed ID: 32340625
[TBL] [Abstract][Full Text] [Related]
12. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis.
Koyama S; Hata S; Witt CC; Ono Y; Lerche S; Ojima K; Chiba T; Doi N; Kitamura F; Tanaka K; Abe K; Witt SH; Rybin V; Gasch A; Franz T; Labeit S; Sorimachi H
J Mol Biol; 2008 Mar; 376(5):1224-36. PubMed ID: 18222470
[TBL] [Abstract][Full Text] [Related]
13. Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy.
Furlow JD; Watson ML; Waddell DS; Neff ES; Baehr LM; Ross AP; Bodine SC
Physiol Genomics; 2013 Dec; 45(23):1168-85. PubMed ID: 24130153
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
15. Muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy.
Khalil RM; Abdo WS; Saad A; Khedr EG
Mol Cell Biochem; 2018 Jul; 444(1-2):161-168. PubMed ID: 29198019
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.
Tabony AM; Yoshida T; Galvez S; Higashi Y; Sukhanov S; Chandrasekar B; Mitch WE; Delafontaine P
Hypertension; 2011 Oct; 58(4):643-9. PubMed ID: 21844485
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
18. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
19. A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting.
Files DC; D'Alessio FR; Johnston LF; Kesari P; Aggarwal NR; Garibaldi BT; Mock JR; Simmers JL; DeGorordo A; Murdoch J; Willis MS; Patterson C; Tankersley CG; Messi ML; Liu C; Delbono O; Furlow JD; Bodine SC; Cohn RD; King LS; Crow MT
Am J Respir Crit Care Med; 2012 Apr; 185(8):825-34. PubMed ID: 22312013
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Morales MG; Olguín H; Di Capua G; Brandan E; Simon F; Cabello-Verrugio C
Clin Sci (Lond); 2015 Sep; 129(6):461-76. PubMed ID: 25989282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
